Atlanthera is a drug discovery company focused on bone diseases and bone cancer treatments. The growing medical need and the lack of effective treatments for bone tumors gave rise to Atlanthera in 2011, a drug discovery company focused on bone diseases and created in collaboration with U957 INSERM laboratory. Specialized in the discovery of innovative molecules for the treatment of bone diseases, Atlanthera has developed a portfolio of new chemical molecules based on the vectorization of Active Pharmaceutical Ingredients to bone tissue. Using this concept, Atlanthera has developed novel treatments that specifically target bone tumor and are able to locally deliver high concentration of active molecules and limit systemic adverse effects. 4 worldwide patents have been applied for.
Our vision: Be the leader in bone-targeted drug delivery to cure bone cancer and metastases
Atlanthera can rely on a very high-qualified Team and a worldwide-known experts network
Our concept: Bone-targeted delivery of anti-cancer drug